» Articles » PMID: 39768536

The Diagnostic Accuracy of an Electrocardiogram in Pulmonary Hypertension and the Role of "R V1, V2 + S I, AVL - S V1"

Overview
Journal J Clin Med
Specialty General Medicine
Date 2025 Jan 8
PMID 39768536
Authors
Affiliations
Soon will be listed here.
Abstract

: Pulmonary hypertension (PH) can cause characteristic electrocardiographic (ECG) changes due to right ventricular hypertrophy and/or strain. The aims of the present study were to explore the diagnostic accuracy of ECG parameters for the diagnosis of PH, applying the recently adjusted mean pulmonary artery pressure (mPAP) threshold of >20 mmHg, and to determine the role of "R V1, V2 + S I, aVL - S V1". : Between July 2012 and November 2023, 100 patients without PH, with pulmonary arterial hypertension, or with chronic thromboembolic pulmonary hypertension were retrospectively enrolled. : The sensitivity and specificity of the ECG parameters for the diagnosis of PH varied from 3 to 98% and from 3 to 100% (means: 39% and 87%). After optimising the parameters' cut-offs, the mean sensitivity (39% to 66%) increased significantly but the mean specificity (87% to 74%) slightly decreased. "R V1, V2 + S I, aVL - S V1" was able to predict an mPAP >20 mmHg (OR: 34.33; < 0.001) and a pulmonary vascular resistance >5 WU (OR: 17.14, < 0.001) but could not predict all-cause mortality. : Even with improved cut-offs, ECG parameters alone are not able to reliably diagnose or exclude PH because of their low sensitivity. However, they still might be helpful to reveal a suspicion of PH, especially in early diagnostic stages, e.g., in primary care with general practitioners or non-specialised cardiologists and pulmonologists. "R V1, V2 + S I, aVL - S V1" was able to predict the diagnosis of (severe) PH but could not predict all-cause mortality. Nevertheless, it can still be useful in risk stratification.

References
1.
Wiedenroth C, Rolf A, Steinhaus K, Adameit M, Kriechbaum S, Haas M . Riociguat and balloon pulmonary angioplasty improve prognosis in patients with inoperable chronic thromboembolic pulmonary Hypertension. J Heart Lung Transplant. 2022; 42(1):134-139. DOI: 10.1016/j.healun.2022.08.011. View

2.
Didden E, Lee E, Wyckmans J, Quinn D, Perchenet L . Time to diagnosis of pulmonary hypertension and diagnostic burden: A retrospective analysis of nationwide US healthcare data. Pulm Circ. 2023; 13(1):e12188. PMC: 9843478. DOI: 10.1002/pul2.12188. View

3.
Kovacs G, Berghold A, Scheidl S, Olschewski H . Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review. Eur Respir J. 2009; 34(4):888-94. DOI: 10.1183/09031936.00145608. View

4.
Hendriks P, Kauling R, Geenen L, Eindhoven J, Roos-Hesselink J, Boomars K . Role of the electrocardiogram in the risk stratification of pulmonary hypertension. Heart. 2022; 109(3):208-215. DOI: 10.1136/heartjnl-2022-321475. View

5.
Lahm T, Douglas I, Archer S, Bogaard H, Chesler N, Haddad F . Assessment of Right Ventricular Function in the Research Setting: Knowledge Gaps and Pathways Forward. An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2018; 198(4):e15-e43. PMC: 6835085. DOI: 10.1164/rccm.201806-1160ST. View